![]() ![]() Pursuant to the Transaction, the Company's issued and outstanding share capital consists of 40,200,766 basic shares outstanding and 48,088,558 shares outstanding on a fully diluted basis. The amalgamated company now holds Novamind Ventures' assets as a wholly-owned subsidiary of the Company, and the resulting company will operate under the name "Novamind Inc.". The Transaction was completed by way of a three-cornered amalgamation, pursuant to which Novamind Ventures amalgamated with a wholly-owned Ontario subsidiary of the Company. In addition, prior to closing of the Transaction, the subscription receipts of Novamind Ventures automatically converted into common shares of Novamind Ventures in accordance with their terms and the gross proceeds of CAD$10.0 million from the affiliated financing were released from escrow. Concurrent with closing of the Transaction, the Company also converted its outstanding debentures and debenture warrants in consideration for the issuance of an aggregate 916,640 post-consolidation Shares, resulting in 1,372,017 Shares being outstanding at the time of Closing of the Transaction. Prior to closing the Transaction, the Company completed a name change from "Hinterland Metals Inc." to "Novamind Inc." and a consolidation of its common shares (the " Shares") on the basis of one (1) post-consolidation Share for every twenty-five (25) pre-consolidation Shares. We look forward to engaging with the investment community and the many stakeholders aligned with our mission to enable safe, legal access to psychedelics and to advance research for psychedelic medicine." Yaron Conforti, Chief Executive Officer and Director of Novamind, commented, "The completion of this transaction is an important milestone en route to Novamind's expected public listing on January 5 th. ![]() The Company will carry on the business of Novamind Ventures, a leading mental health company specialized in psychedelic-assisted psychotherapy. (" Novamind Ventures") by way of a three-cornered amalgamation (the " Transaction"). (formerly Hinterland Metals Inc.) (" Novamind" or the " Company"), is pleased to announce that it has completed its previously announced reverse takeover of Novamind Ventures Inc. TORONTO, ON / ACCESSWIRE / Decem/ Novamind Inc. Any failure to comply with this restriction may constitute a violation of U.S. Newswire Services or for dissemination in the United States. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.Public listing (CSE:NM) expected to occur on or about January 5, 2021 ![]() įor more of the latest info on Cannabis, check out the Cannabis Trending News hub. New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks. Each Warrant entitles the holder to purchase common shares at an exercise price of CDN$0.50 per common share at any time on or prior to January 26, 2027. Pursuant to the PP, the company issued 4,750,000 common shares, 7,750,000 common share equivalents (consisting of pre-funded warrants exercisable into common shares) and warrants to purchase up to an aggregate of 12,500,000 common shares, at a purchase price of CDN$0.40 per common share and associated warrant. ( CSE.NM) – a leading mental health company specialized in psychedelic medicine – has announced that it has closed its previously announced private placement (PP) to an institutional investor of its common shares and warrants to purchase common shares for gross proceeds to the company of approximately CDN$5 million. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |